Status:
COMPLETED
COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box
Lead Sponsor:
University of British Columbia
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The trial will be done to determine the impact of a barrier enclosure, COVID (coronavirus disease -19) barrier box on endotracheal intubation attempts, and duration. This study will be a prospective, ...
Detailed Description
Purpose: To assess the time to tracheal intubation (TTI) and first-pass success rate for attending anesthesiologists intubating with COVID-related modifications with or without the use of a COVID bar...
Eligibility Criteria
Inclusion
- Patient Participant
- Healthy American Society of Anesthesiologists (ASA) Classification 1 or 2 adults scheduled for elective surgery requiring orotracheal intubation
- 18 years of age or older
- COVID negative (As defined by negative COVID swab plus absence of screening symptoms as defined by: Fever, Cough, Shortness of breath or difficulty breathing, Chills, Repeated shaking with chills, Muscle pain, Headache, Sore throat, New loss of taste or smell)
- Anesthesiologist Participant
- Attending Anesthesiologist
- Have performed at least 5 prior intubations using McGrath videolaryngoscopes
- Have performed at least 5 prior endotracheal intubations with the locally instituted COVID-related modifications
- Must not have more than one prior experience with using the COVID barrier box on real patients (Prior to the study start; not inclusive of intubations done in the context of this study)
- Have performed at least one practice intubation on a manikin with the COVID barrier box prior to initiation of study
- Patient Participant
Exclusion
- Patient refusal, inability to consent or cooperate
- Claustrophobia
- Body habitus not allowing physical fit into COVID barrier box
- History of documented difficult airway
- Risk factors for difficult airway (Mallampati 3 or 4, thyromental distance less than 6 cm, interincisor distance less than 4 cm, upper lip bite test 2 or 3, body mass index (BMI) 30 or above, macroglossia, airway edema, blood in airway, cervical immobility, or any other concerning features deemed by attending anesthesiologist)
- Risk factors for gastric aspiration
- Allergy to rocuronium
- Anesthesiologist Participant
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04366141
Start Date
May 1 2020
End Date
February 1 2021
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Health Care
Vancouver, British Columbia, Canada, V6Z 1Y6